Results Among 1870 patients receiving maintenance dialysis, 1569 had no prior COVID-19.
Patients without prior COVID-19 had declining titers over time. Among 443 recipients of …

Medication-related problems are a leading cause of morbidity and mortality. Patients requiring
dialysis are at heightened risk for adverse drug reactions because of the prevalence of …

As of October 2021, 3 SARS-CoV-2 vaccines are available in the United States, and all
appear highly effective in the general population. Studies suggest high seroresponse to …

Rationale & Objective Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections are likely underdiagnosed, but the degree of underdiagnosis among patients receiving …

Background Vaccination against hepatitis B virus (HBV) is recommended for dialysis
patients. Two reports comparing seroprotection (SP) rates following HepB and HepB-CpG in …

Background: Maintenance dialysis patients’ SARS-CoV-2 receptor binding spike antibody (RBD
s-Ab) levels decline rapidly in the months following initial vaccination. We describe the …

Background: Preventing COVID-19 infection or its consequences through SARS-CoV-2
vaccination in maintenance dialysis patients, a high risk population, is imperative. We …

Background: Durability of SARS-CoV-2 receptor-binding domain spike antibody (RBD s-Ab)
levels among patients receiving dialysis after COVID-19 [WDE1] is unknown [EL2] beyond 6 …

Background: Maintenance dialysis patients are highly susceptible to SARS-CoV-2 and
historically, when infected,> 60% need emergency department or hospital care and mortality …

Background: Vaccines against SARS-CoV-2 are highly effective in the general population;
however, their efficacy may be diminished in maintenance dialysis patients, a population …